FDA Inspection 1010216 — Tris Pharma Inc.
The FDA completed an inspection of Tris Pharma Inc. on Mar 20, 2017 in Monmouth Junction, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 20, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Monmouth Junction, NJ (United States)